Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Sales | 6,828 | 17,497 | 28,584 | 14,762 | 15,534 |
| Gross Profit | 6,828 | 17,497 | 28,584 | 14,762 | 15,534 |
| Operating Expenses | 22,633 | 31,219 | 32,521 | 32,205 | 33,214 |
| Operating Income | -15,805 | -13,722 | -3,937 | -17,443 | -17,680 |
| Other Income | 1,207 | 1,502 | 1,568 | 1,958 | 2,408 |
| Pre-tax Income | -14,598 | -12,220 | -2,369 | -15,485 | -15,272 |
| Net Income Continuous | -14,598 | -12,220 | -2,369 | -15,485 | -15,272 |
| Net Income | $-14,598 | $-12,220 | $-2,369 | $-15,485 | $-15,272 |
| EPS Basic Total Ops | -0.48 | -0.40 | -0.08 | -0.52 | -0.52 |
| EPS Basic Continuous Ops | -0.48 | -0.40 | -0.08 | -0.52 | -0.53 |
| EPS Diluted Total Ops | -0.48 | -0.40 | -0.08 | -0.52 | -0.52 |
| EPS Diluted Continuous Ops | -0.48 | -0.40 | -0.08 | -0.52 | -0.53 |
| EBITDA(a) | $-14,283 | $-12,242 | $-2,579 | $-16,234 | $-16,888 |